Curcuma plants in Asia which have found medicinal-use, especially for the included turmeric, and derivative crude drugs are here briefly reviewed. The Indian literature mentions the absence of authentic type specimens of
C. aromatic Salisb. pointing to confusion of “
C. aromatica” with different plants whose morphological characteristics match the original description provided by A. Salisbury. Indeed, plants native in south India once prefixed with
C. aromatica have now been renamed as
C. zanthorrhiza. This same phenomenon has also occurred with
C. zedoaria, not only in India but also frequently in other Asian countries. As we clarified previously, crude drugs produced in Japan, Thailand and India that are recognized as derivatives of
C. aromatica feature different nucleotide sequences in the plastid
trnK gene. Genetic analysis of this region has provided useful information to discriminate and identify Chinese and Japanese
Curcuma plants and drugs. However, the
trnK gene sequence suffers from limitations to classify more closely linked species, and
C. zedoaria and
C. zanthorrhiza could not be differentiated solely on the basis of their
trnK information. Therefore a more detailed classification system has been a high priority. Accordingly, another method for discriminating
Curcuma species by intron length polymorphism (ILP) markers in genes encoding diketide-CoA synthase and curcumin synthase has been developed. Grouping based on ILP markers is not only consistent with results based on the
trnK gene but also gives more details. Taking
C. longa as an example, specimens from Asian countries were geographically distinguishable by means of this method, suggesting its use as a potential tool for further taxonomic study. In additional chemical studies, HPLC based quantitative analysis of curcuminoids in turmeric samples purchased from Japanese markets using curcumin as the standard, indicated that the content of curcuminoids in turmeric should be in the range from 1.0 to 5.0% for validity.
View full abstract